Key facts
- Notable investors include A W Brunn International, Penteract Capital Partners.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Donas
- ·The full record, as it builds
Funding rounds
No funding rounds for Donas are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Donas
Provider of human blood products intended for research and quality assurance in laboratories, companies, and research institutions. The company offers quality standards and fresh processed range of blood products, including whole blood, buffy coats, plasma, and serum, enabling clients to get supported in the research process.
- Sector
- Healthcare
- HQ
- Munich, Germany
- Founded
- 2021
- Website
- donas.eu/
- Ownership
- Privately Held (backing)
Donas doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Donas shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Donas in its N-PORT filings yet. We sweep new filings monthly.